• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reactogenicity and Concomitant Administration of the COVID-19 Booster and Influenza Vaccine.

作者信息

Hall Kathryn T, Stone Valerie E, Ojikutu Bisola

机构信息

Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Boston Public Health Commission, Boston, Massachusetts.

出版信息

JAMA Netw Open. 2022 Jul 1;5(7):e2222246. doi: 10.1001/jamanetworkopen.2022.22246.

DOI:10.1001/jamanetworkopen.2022.22246
PMID:35838673
Abstract
摘要

相似文献

1
Reactogenicity and Concomitant Administration of the COVID-19 Booster and Influenza Vaccine.新冠病毒加强针与流感疫苗的反应原性及联合接种
JAMA Netw Open. 2022 Jul 1;5(7):e2222246. doi: 10.1001/jamanetworkopen.2022.22246.
2
Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US.美国同时接种 COVID-19 mRNA 加强针和流感疫苗的反应原性。
JAMA Netw Open. 2022 Jul 1;5(7):e2222241. doi: 10.1001/jamanetworkopen.2022.22241.
3
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study.≥65 岁成年人中同时接种高剂量四价流感疫苗和 mRNA-1273 新冠疫苗第三针的安全性和免疫原性：一项 2 期、随机、开放标签研究。
Lancet Respir Med. 2022 Apr;10(4):392-402. doi: 10.1016/S2213-2600(21)00557-9. Epub 2022 Feb 1.
4
Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children.菲律宾儿童中使用白喉-破伤风-全细胞百日咳-乙型肝炎-低抗原含量b型流感嗜血杆菌联合疫苗进行三剂基础免疫和加强免疫的免疫原性、反应原性及安全性
Hum Vaccin. 2010 Aug;6(8):664-72. doi: 10.4161/hv.6.8.12155.
5
Safety monitoring of COVID-19 vaccines - Lessons learned from the 1976 national influenza immunization program about detecting rare vaccine-related severe adverse events in emergency mass-vaccination programs.2019冠状病毒病疫苗的安全性监测——从1976年全国流感免疫计划中汲取的经验教训，关于在紧急大规模疫苗接种计划中检测罕见的疫苗相关严重不良事件。
Vaccine. 2021 Apr 15;39(16):2187-2189. doi: 10.1016/j.vaccine.2021.03.015. Epub 2021 Mar 20.
6
Influenza vaccine update, 2021-22.2021-2022 年度流感疫苗更新。
J Fam Pract. 2021 Oct;70(8):399-402. doi: 10.12788/jfp.0277.
7
Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.在12至23月龄婴儿中，同时接种一剂麻疹、腮腺炎、风疹和水痘联合减毒活疫苗（ProQuad®）与一剂六价疫苗加强针的免疫原性和安全性。
Vaccine. 2015 May 11;33(20):2379-86. doi: 10.1016/j.vaccine.2015.02.070. Epub 2015 Mar 9.
8
The new DTPw-HBV-Hib combination vaccine can be used at the who schedule with a monovalent dose of hepatitis B vaccine at birth.新型白百破-乙肝- Hib联合疫苗可按照世界卫生组织的免疫程序，在出生时与一剂单价乙肝疫苗同时接种。
Southeast Asian J Trop Med Public Health. 1998 Dec;29(4):772-8.
9
A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America.一种用于拉丁美洲婴儿初次和加强免疫接种的新型白喉、破伤风、百日咳、乙肝和b型流感嗜血杆菌联合疫苗。
Rev Panam Salud Publica. 2006 Mar;19(3):179-88. doi: 10.1590/s1020-49892006000300006.
10
Safety and reactogenicity of DTPa-HBV-IPV/Hib and DTPa-IPV/I-Hib vaccines in a post-marketing surveillance setting.在上市后监测环境中，吸附无细胞百白破-乙肝-脊髓灰质炎灭活疫苗/ b型流感嗜血杆菌结合疫苗和吸附无细胞百白破-脊髓灰质炎灭活疫苗/ b型流感嗜血杆菌结合疫苗的安全性和反应原性。
Southeast Asian J Trop Med Public Health. 2011 Jan;42(1):138-47.

引用本文的文献

1
COVID-19 Vaccination Enhances the Immunogenicity of Seasonal Influenza Vaccination in the Elderly.新冠病毒疫苗接种增强老年人季节性流感疫苗的免疫原性。
Vaccines (Basel). 2025 May 16;13(5):531. doi: 10.3390/vaccines13050531.
2
Immunogenicity and safety of different combinations involving a third booster dose of SARS-CoV-2 inactivated vaccine, inactivated quadrivalent influenza vaccine, and 23-valent pneumococcal polysaccharide vaccine in adults aged ≥60 years: a phase 4, randomized, open-label study.不同组合的免疫原性和安全性，涉及第三剂加强针 SARS-CoV-2 灭活疫苗、灭活四价流感疫苗和 23 价肺炎球菌多糖疫苗，在年龄≥60 岁的成年人中的应用：一项 4 期、随机、开放标签研究。
Front Immunol. 2024 Aug 20;15:1437267. doi: 10.3389/fimmu.2024.1437267. eCollection 2024.
3
Concomitant administration of seasonal influenza and COVID-19 mRNA vaccines.季节性流感和 COVID-19 mRNA 疫苗同时接种。
Emerg Microbes Infect. 2024 Dec;13(1):2292068. doi: 10.1080/22221751.2023.2292068. Epub 2024 Jan 18.
4
Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents.英国青少年对 BNT162b2 COVID-19 和减毒流感疫苗的免疫反应在年龄和性别上的差异。
Front Immunol. 2023 Oct 6;14:1248630. doi: 10.3389/fimmu.2023.1248630. eCollection 2023.
5
The Effect of Psychological Factors on COVID-19 Vaccination Side Effects: A Cross-Sectional Survey in South Korea.心理因素对新冠疫苗接种副作用的影响：韩国的一项横断面调查
Psychiatry Investig. 2023 Sep;20(9):808-817. doi: 10.30773/pi.2023.0116. Epub 2023 Sep 19.
6
Combining Influenza and COVID-19 Booster Vaccination Strategy to Improve Vaccination Uptake Necessary for Managing the Health Pandemic: A Systematic Review and Meta-Analysis.结合流感和新冠病毒加强疫苗接种策略以提高应对健康大流行所需的疫苗接种率：一项系统评价和荟萃分析
Vaccines (Basel). 2022 Dec 21;11(1):16. doi: 10.3390/vaccines11010016.